| Literature DB >> 31911936 |
Laura K Triantafylidis1, Sarah C Phillips2,3,4, Chelsea E Hawley5,6, Andrea Wershof Schwartz7,8.
Abstract
Introduction: Intensive glucose lowering in older adults with diabetes leads to increased risks with minimal benefits. Surveys indicate that clinician confidence for individualizing glycemic goals and regimens remains low. We created an interactive workshop and clinical tool kit to improve clinician knowledge of safe diabetes management in older adults.Entities:
Keywords: Deprescribing; Deprescriptions; Diabetes; Editor's Choice; Geriatric Diabetes; Older Adults; Safe Prescribing
Mesh:
Year: 2019 PMID: 31911936 PMCID: PMC6944249 DOI: 10.15766/mep_2374-8265.10845
Source DB: PubMed Journal: MedEdPORTAL ISSN: 2374-8265
Workshop Attendance by Profession and Designation (N = 30)
| Profession and Designation | No. (%) |
|---|---|
| Medicine | 21 (70) |
| Geriatric medicine fellow | 6 (20) |
| Internal/family medicine resident | 14 (47) |
| Medical student | 1 (3) |
| Pharmacy | 9 (30) |
| Pharmacy resident | 6 (20) |
| Pharmacy student | 3 (10) |
Self-Efficacy Results, Pre- Versus Postintervention (N = 30)
| Self-Efficacy Evaluation | Presurvey: No. (%) of Confident Learners | Postsurvey: No. (%) of Confident Learners | Delta | |
|---|---|---|---|---|
| Identify patients who are at an increased risk for hypoglycemia | 20 (67) | 30 (100) | 33% | <.05 |
| Choose an appropriate hemoglobin A1c and blood glucose goal for an older adult | 24 (80) | 29 (97) | 17% | <.05 |
| Determine which diabetic medication is least likely to cause hypoglycemia | 16 (53) | 29 (97) | 44% | <.05 |
| Deprescribe a diabetic regimen to minimize the risk of adverse drug side effects | 6 (20) | 28 (93) | 73% | <.05 |
| Overall average | 55% | 97% | 42% | <.05 |
Self-efficacy was assessed via a 5-point Likert scale (1 = not at all confident, 2 = not confident, 3 = neutral, 4 = somewhat confident, 5 = extremely confident); learners were qualified as confident if their response was 4 or 5.
Knowledge Results, Pre- Versus Postintervention (N = 30)
| Knowledge Evaluation | Presurvey: No. (%) of Correct Answers | Postsurvey: No. (%) of Correct Answers | Delta | |
|---|---|---|---|---|
| Objective 1: List safety and efficacy characteristics of antihyperglycemic agents | ||||
| Question: hypoglycemic risk of oral agents | 15 (50) | 27 (90) | 40% | <.05 |
| Question: hypoglycemic risk of insulins | 23 (77) | 25 (83) | 6% | .52 |
| Objective 2: Develop individualized glycemic goals for older adults with diabetes | ||||
| Question: case example to individualize A1c goal | 16 (53) | 24 (80) | 24% | <.05 |
| Objective 3: Implement geriatric prescribing principles for antihyperglycemic agents | ||||
| Question: case example to prescribe diabetes medications | 19 (63) | 24 (80) | 17% | .15 |
| Question: case example to deprescribe diabetes medications | 19 (63) | 21 (70) | 7% | .58 |
| Overall average | 61% | 81% | 19% | <.05 |
Knowledge was assessed via multiple-choice questions with four answer choice options and one correct answer.